AbbVie Inc. (ABBV) Operating cash flow 2016–2025
AbbVie Inc. (ABBV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$19.0BFY2025 · since FY2016: $7.0B → $19.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $19.0B | +1.2% |
| FY2024 | $18.8B | -17.7% |
| FY2023 | $22.8B | -8.4% |
| FY2022 | $24.9B | +9.5% |
| FY2021 | $22.8B | +29.5% |
| FY2020 | $17.6B | +32.0% |
| FY2019 | $13.3B | -0.8% |
| FY2018 | $13.4B | +34.8% |
| FY2017 | $10.0B | +41.5% |
| FY2016 | $7.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net incomeABBV Net marginABBV Gross profitABBV Gross marginABBV Operating incomeABBV Operating marginABBV Free cash flowABBV Capital expendituresABBV Return on equityABBV Stock buybacksABBV Dividends paidABBV Total assetsABBV Total liabilitiesABBV Shareholders’ equityABBV overview →